FDA Adverse Event Injury Summary report: N

OMNIPOD 5 POD

MDR report key: 20608544 · Received November 5, 2024

Report

Report Number
3004464228-2024-44882
Event Type
Injury
Date Received
November 5, 2024
Date of Event
October 25, 2024
Report Date
November 5, 2024
Manufacturer
INSULET CORPORATION
Product Code
QFG
UDI-DI
20385083000432
PMA / PMN Number
K231826
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MA, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 0

ACCORDING TO THE COMPLAINANT THE DEVICE WILL NOT BE RETURNED FOR INVESTIGATION. WE ARE UNABLE TO DETERMINE IF ANY PRODUCT CONDITION COULD HAVE CONTRIBUTED TO THE REPORTED HOSPITALIZATION AND HYPERGLYCEMIA/HYPOGLYCEMIA. LOT RELEASE RECORDS WERE REVIEWED AND THE PRODUCT LOT MET ALL ACCEPTANCE CRITERIA. SPECIFICALLY, A POD IS PAIRED TO A PDM AND PUT THROUGH SIMULATED USE TESTING INCLUDING COMMUNICATING WITH THE PDM, DEPLOYMENT, DELIVERING FLUID, OCCLUSION DETECTION, AND FREEDOM FROM HAZARD ALARMS.

Description of Event or Problem · 0

IT WAS REPORTED THAT THE PATIENT HAD BEEN HOSPITALIZED AT PRINCE CHARLES HOSPITAL IN MERTHYR TYDFIL WITH HYPERGLYCEMIA. THE PATIENT'S BLOOD GLUCOSE LEVELS ROSE TO 29.5 MMOL/L (531 MG/DL) WHILE WEARING THE POD FOR BETWEEN 5 AND 24 HOURS. THE DOCTOR REMOVED THE POD FROM THE INFUSION SITE (LEG) ON (B)(6) 2024. WITHIN ONE HOUR, THE PATIENT WENT INTO HYPOGLYCEMIA AND THE BG LEVELS DROPPED AS LOW AS 3.6 MMOL/L (64.8 MG/DL). THE MEDICAL TEAM STATED THIS MAY HAVE BEEN DUE TO THE PATIENT'S HORMONES AND PROVIDED THE PATIENT WITH FLUIDS. THE PATIENT'S MOTHER STATED THEY ENDED UP CHANGING 6 PODS DURING THE HOSPITALIZATION. THE PATIENT WAS DISCHARGED ON (B)(6) 2024.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
120598 OMNIPOD 5 POD AUTOMATED INSULIN DELIVERY SYSTEM QFG INSULET CORPORATION PT-001443 PH1K01312431 20385083000432

Patients

Seq Age Sex Outcome Treatment
1 10 YR Female Hospitalization